Clinical Trials Browser

Phase 3 × Hematologic Neoplasms × Doxorubicin × Clear all

NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Phase 3 Completed

401 enrolled 14 charts

Other hematologic neoplasm

Nausea, Vomiting, Hematologic Neoplasms

NCT00215943 2014-04-17

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Phase 3 Terminated

90 enrolled 10 charts

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms